CleanSpark Valuation
Is CLSK * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CLSK * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CLSK * (MX$329) is trading below our estimate of fair value (MX$560.24)
Significantly Below Fair Value: CLSK * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CLSK *?
Other financial metrics that can be useful for relative valuation.
What is CLSK *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$4.33b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 20.1x |
Enterprise Value/EBITDA | 71.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does CLSK *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 9.3x | ||
MARA Marathon Digital Holdings | 12.5x | 32.3% | US$5.2b |
BILL BILL Holdings | 5.6x | 13.1% | US$6.6b |
BRZE Braze | 9.2x | 18.8% | US$4.2b |
RIOT Riot Platforms | 10x | 28.1% | US$3.0b |
CLSK * CleanSpark | 19.1x | 46.1% | Mex$4.3b |
Price-To-Sales vs Peers: CLSK * is expensive based on its Price-To-Sales Ratio (19.1x) compared to the peer average (9.3x).
Price to Earnings Ratio vs Industry
How does CLSK *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: CLSK * is expensive based on its Price-To-Sales Ratio (19.1x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is CLSK *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 19.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CLSK *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$329.00 | Mex$397.13 +20.7% | 21.2% | Mex$510.60 | Mex$255.30 | n/a | 6 |
Apr ’25 | Mex$309.90 | Mex$385.13 +24.3% | 22.6% | Mex$498.73 | Mex$232.74 | n/a | 6 |
Mar ’25 | Mex$305.00 | Mex$255.85 -16.1% | 36.8% | Mex$459.50 | Mex$170.19 | n/a | 6 |
Feb ’25 | Mex$142.22 | Mex$204.54 +43.8% | 18.8% | Mex$244.75 | Mex$137.89 | n/a | 6 |
Jan ’25 | n/a | Mex$205.38 0% | 18.8% | Mex$245.76 | Mex$138.46 | n/a | 6 |
Dec ’24 | Mex$109.50 | Mex$172.83 +57.8% | 26.7% | Mex$240.76 | Mex$91.14 | n/a | 6 |
Nov ’24 | n/a | Mex$177.53 0% | 27.3% | Mex$249.37 | Mex$94.41 | n/a | 6 |
Oct ’24 | n/a | Mex$191.73 0% | 14.6% | Mex$238.59 | Mex$170.42 | n/a | 4 |
Sep ’24 | Mex$74.50 | Mex$191.73 +157.4% | 14.6% | Mex$238.59 | Mex$170.42 | n/a | 4 |
Aug ’24 | Mex$104.00 | Mex$159.87 +53.7% | 22.9% | Mex$201.94 | Mex$100.97 | n/a | 4 |
Jul ’24 | n/a | Mex$137.02 0% | 30.6% | Mex$205.53 | Mex$102.76 | n/a | 4 |
Jun ’24 | n/a | Mex$139.44 0% | 30.6% | Mex$209.17 | Mex$104.58 | n/a | 4 |
May ’24 | n/a | Mex$140.93 0% | 34.6% | Mex$218.22 | Mex$90.92 | n/a | 4 |
Apr ’24 | n/a | Mex$139.93 0% | 38.3% | Mex$223.89 | Mex$93.29 | Mex$309.90 | 4 |
Mar ’24 | n/a | Mex$139.93 0% | 38.3% | Mex$223.89 | Mex$93.29 | Mex$305.00 | 4 |
Feb ’24 | n/a | Mex$158.05 0% | 38.5% | Mex$237.08 | Mex$98.78 | Mex$142.22 | 4 |
Jan ’24 | n/a | Mex$158.05 0% | 38.5% | Mex$237.08 | Mex$98.78 | n/a | 4 |
Dec ’23 | n/a | Mex$184.77 0% | 26.7% | Mex$237.56 | Mex$118.78 | Mex$109.50 | 3 |
Nov ’23 | n/a | Mex$184.77 0% | 26.7% | Mex$237.56 | Mex$118.78 | n/a | 3 |
Oct ’23 | n/a | Mex$205.07 0% | 12.1% | Mex$238.15 | Mex$178.61 | n/a | 3 |
Sep ’23 | n/a | Mex$205.07 0% | 12.1% | Mex$238.15 | Mex$178.61 | Mex$74.50 | 3 |
Aug ’23 | n/a | Mex$156.28 0% | 22.2% | Mex$203.84 | Mex$122.30 | Mex$104.00 | 3 |
Jul ’23 | Mex$84.14 | Mex$247.78 +194.5% | 19.7% | Mex$312.99 | Mex$195.62 | n/a | 3 |
Jun ’23 | Mex$115.42 | Mex$460.75 +299.2% | 30.4% | Mex$600.98 | Mex$320.52 | n/a | 2 |
May ’23 | n/a | Mex$472.91 0% | 30.4% | Mex$616.85 | Mex$328.98 | n/a | 2 |
Apr ’23 | n/a | Mex$472.91 0% | 30.4% | Mex$616.85 | Mex$328.98 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.